Aromatherapy for Older Adults at Risk of Metabolic Syndrome
Effects of Aromatherapy on Sleep Quality and Quality of Life for Older Adults at Risk of Metabolic Syndrome in the Community
This study tests if using lavender aromatherapy can help older adults at risk of metabolic syndrome sleep better and improve their overall quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | National Taipei University of Nursing and Health Sciences Academic / other |
| Locations | 1 site (Hsinchu, East Dist) |
| Trial ID | NCT05987020 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effects of aromatherapy on sleep quality and overall quality of life in older adults at risk of metabolic syndrome. It involves a longitudinal, randomized control design with 64 participants from community care bases in Hsinchu City. The experimental group will receive lavender essential oil, while the control group will receive a placebo. Various validated questionnaires will be used to assess sleep quality and quality of life before and after the intervention.
Who should consider this trial
Good fit: Ideal candidates are community-dwelling adults aged 65 and older who exhibit at least one risk factor for metabolic syndrome and have normal olfactory function.
Not a fit: Patients with severe respiratory diseases or those who do not meet the criteria for metabolic syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and sleep for older adults at risk of metabolic syndrome.
How similar studies have performed: Previous studies have indicated positive outcomes from aromatherapy interventions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Students aged 65 or above in community care bases 2. People with normal sense of smell 3. No severe respiratory disease 4. Have any one of the metabolic syndrome risk factors According to the definition of the National Health Service: 1. Abdominal obesity: waist circumference ≧90cm for men, waist circumference ≧80cm for women; 2. High blood pressure: systolic blood pressure ≧ 130mmHg or diastolic blood pressure ≧ 85mmHg, or taking medication for hypertension prescribed by a doctor; 3. High fasting blood sugar: fasting blood sugar ≧100mg/dL, or taking a doctor's prescription for diabetes treatment; 4. High fasting triglycerides: ≧150mg/dL, or taking medicines for lowering triglycerides prescribed by doctors; 5. Low high-density lipoprotein cholesterol: men \<40mg/dL, women \<50mg/dL, the above five items are risk factors, and three or more items are met as metabolic syndrome. 5. Complaints of sleep disorders 6. Those who agree and can cooperate with research activities Exclusion Criteria: 1. Those who are allergic to essential oils 2. Diagnosed with dementia, mental illness: such as depression 3. Cancer patients 4. Those who are currently using aromatherapy/have participated in or used aromatherapy-related activities within one month 5. Currently there is a wound on the shoulder and neck
Where this trial is running
Hsinchu, East Dist
- Hsinchu Cathay General Hospital — Hsinchu, East Dist, Taiwan (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.